# Study on [14C]HMPL-453（FGFR Inhibitor） in Healthy Chinese Adult Male Subjects

> **NCT07644442** · PHASE1 · COMPLETED · sponsor: **Hutchmed** · enrollment: 6 (actual)

## Conditions studied

- Mass Balance Study

## Interventions

- **DRUG:** HMPL-453

## Key facts

- **NCT ID:** NCT07644442
- **Lead sponsor:** Hutchmed
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-26
- **Primary completion:** 2025-03-14
- **Final completion:** 2025-03-14
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07644442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07644442, "Study on [14C]HMPL-453（FGFR Inhibitor） in Healthy Chinese Adult Male Subjects". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07644442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*